Largest Australian (ASX) Pharmaceuticals & Biotech Stocks by Market Cap

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
CSL CSL	AU$273.72	-3.6%	6.1%	AU$132.8b	AU$327.80	PE32.6x	E13.0%	1.5%
TLX Telix Pharmaceuticals	AU$22.20	-3.1%	141.8%	AU$7.7b	AU$25.62	PE151.1x	E38.3%	n/a
CU6 Clarity Pharmaceuticals	AU$5.97	-15.7%	355.7%	AU$1.9b	AU$8.89	PS166.1x	E68.2%	n/a
MSB Mesoblast	AU$1.49	-16.6%	275.9%	AU$1.8b	AU$1.46	PS186.7x	E61.5%	n/a
NEU Neuren Pharmaceuticals	AU$12.43	-28.2%	-16.2%	AU$1.7b	AU$26.21	PE13.5x	E-9.9%	n/a
PYC PYC Therapeutics	AU$1.83	-1.1%	140.8%	AU$886.6m	AU$3.30	PS38.7x	E34.7%	n/a
OPT Opthea	AU$0.63	-10.7%	50.6%	AU$812.5m	n/a	PS1910.5x	E61.9%	n/a
CUV Clinuvel Pharmaceuticals	AU$13.16	-2.7%	-22.0%	AU$669.3m	AU$28.29	PE18.4x	E26.2%	0.4%
BOT Botanix Pharmaceuticals	AU$0.32	-1.6%	103.2%	AU$572.5m	n/a	PS276.6x	E99.4%	n/a
IMM Immutep	AU$0.28	-16.2%	-3.4%	AU$443.6m	n/a	PS107.9x	E38.6%	n/a
MYX Mayne Pharma Group	AU$4.18	-14.3%	-9.5%	AU$361.1m	AU$6.09	PB0.7x	E110.0%	n/a
IMU Imugene	AU$0.037	-15.9%	-54.9%	AU$297.5m	n/a	PS55.4x	E53.4%	n/a
RAC Race Oncology	AU$1.43	0.7%	55.4%	AU$231.8m	AU$3.67	PS60.9x	E0.1%	n/a
ARX Aroa Biosurgery	AU$0.65	4.0%	-9.7%	AU$219.0m	n/a	PS3.6x	E56.3%	n/a
ALA Arovella Therapeutics	AU$0.18	-12.2%	122.2%	AU$194.9m	n/a	PS97.2x	n/a	n/a
LTP LTR Pharma	AU$1.23	-9.9%	n/a	AU$187.6m	n/a	PS3844.9x	n/a	n/a
DXB Dimerix	AU$0.33	-13.3%	140.7%	AU$186.6m	n/a	PS310.3x	n/a	n/a
GSS Genetic Signatures	AU$0.72	0.3%	44.9%	AU$158.8m	AU$1.10	PS11.8x	E98.6%	n/a
TRJ Trajan Group Holdings	AU$0.98	-12.8%	-18.9%	AU$155.3m	AU$1.40	PB1.5x	E99.2%	n/a
OCC Orthocell	AU$0.61	-4.7%	50.6%	AU$149.4m	n/a	PS27.4x	n/a	n/a
EZZ EZZ Life Science Holdings	AU$2.85	-3.7%	359.7%	AU$127.5m	AU$5.45	PE18.2x	E17.9%	1.1%
VLS Vita Life Sciences	AU$2.06	-0.5%	22.6%	AU$117.7m	n/a	PE12.3x	n/a	4.4%
RCE Recce Pharmaceuticals	AU$0.47	-6.0%	6.8%	AU$106.7m	AU$2.46	PS21.7x	E-53.4%	n/a
PAR Paradigm Biopharmaceuticals	AU$0.27	10.2%	-30.8%	AU$98.1m	n/a	PB4x	E8.8%	n/a